(Q58124865)

2

0 references

Joseph Talafous

3

0 references

Ron Orlando

4

0 references

Michael G. Zagorski

Normal and abnormal biology of the beta-amyloid precursor protein

5

0 references

publication date

January 1997

0 references

published in

Amyloid

0 references

volume

4

0 references

issue

4

0 references

page(s)

240-252

0 references

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

The toxicity in vitro of beta-amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

A beta A4 amyloid precursor protein gene and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Beta-amyloid precursor protein. Location of transmembrane domain and specificity of gamma-secretase cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

In situ characterization of beta-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Solution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Reversible random coil-beta-sheet transition of the Alzheimer beta-amyloid fragment (25-35).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Fibrillogenesis of synthetic amyloid-beta peptides is dependent on their initial secondary structure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Rapid induction of Alzheimer A beta amyloid formation by zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Solvent effects on self-assembly of beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Nicotine inhibits amyloid formation by the beta-peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Solution structure of residues 1-28 of the amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Three-dimensional structures of the amyloid beta peptide (25-35) in membrane-mimicking environment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

The interaction of beta-amyloid protein fragment (12-28) with lipid environments.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Mass spectrometry of peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Alzheimer's beta-amyloid protein is covalently modified when dissolved in formic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

Methodological variables in the assessment of beta amyloid neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129709003835